Warner Chilcott Plc - Ordinary Shares (MM) (WCRX) Cotización

With two companies in "talk", should see more volatility this week.

I have been all day my friend!!!

Lol - take a look ;)

So what about today's PR??? The last one I asked about was over 10 days ago and not a single member here responded. Is this stock just not liked THAT MUCH????

So does today's update mean anything????

my homie!!!!! i got in at 12.88 holding for not long though i need that car

Got in at $12.72 today and holding for the long haul!!!

move

$4 dividend tomorrow

~ Friday! $WCRX ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $WCRX ~ Earnings expected on Friday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=WCRX&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=WCRX&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=WCRX
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=WCRX#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=WCRX+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=WCRX
Finviz: http://finviz.com/quote.ashx?t=WCRX
~ BusyStock: http://busystock.com/i.php?s=WCRX&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=WCRX >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Warner Chilcott plc. is a specialty pharmaceutical company focused on the women’s healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets. It is an integrated company with internal resources focused to the development, manufacture and promotion of its products. It has acquired a number of products through license, co-promotion arrangements or purchase, including ASACOL, ACTONEL, ENABLEX, ESTRACE Cream, FEMHRT and LOESTRIN. On October 8, 2010, Food & Drug Administration (FDA) approved ATELVIA product for the treatment of postmenopausal osteoporosis in the United States. On October 21, 2010, FDA approved LO LOESTRIN FE product for the prevention of pregnancy in the United States. On December 22, 2010, FDA approved WC3026 product for the prevention of pregnancy in the United States.

http://www.google.com/finance?q=WCRX